FDA
FDA Affirms It Will Not Approve Any Generic Forms Of OxyContin Despite Patent Expiration
The Food and Drug Administration (FDA) announced Tuesday that it will not approve generic forms of OxyContin and that, going forward, it will only allow the production and sale of the 2010 form of the drug, which was specially designed to mitigate the abuse of it.
MOST POPULAR
-
Greenland Ice Sheet Melts at Alarming Speed, Satellite Imaging Reveals
-
'Alien Plant' Possibly Related to Ginseng Discovered Near Utah Ghost Town
-
Rare Mastodon Bone Fragments Unearthed in NY Home After Homeowner Spent Two and a Half Days Digging in Backyard
-
Northern Lights Could Grace the US Skies Tonight – Here’s Where to Look
-
Antarctica's Deception Island: A Volcano-Formed Sanctuary in the Heart of the Southern Ocean
